- Home
- STHO vs TVGN Comparison
STHO vs TVGN Comparison
Compare STHO & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STHO
- TVGN
- Stock Information
- Founded
- STHO N/A
- TVGN 2020
- Country
- STHO United States
- TVGN United States
- Employees
- STHO N/A
- TVGN N/A
- Industry
- STHO Real Estate
- TVGN Blank Checks
- Sector
- STHO Real Estate
- TVGN Finance
- Exchange
- STHO Nasdaq
- TVGN Nasdaq
- Market Cap
- STHO 178.5M
- TVGN 109.7M
- IPO Year
- STHO N/A
- TVGN N/A
- Fundamental
- Price
- STHO $13.01
- TVGN $0.42
- Analyst Decision
- STHO
- TVGN
- Analyst Count
- STHO 0
- TVGN 0
- Target Price
- STHO N/A
- TVGN N/A
- AVG Volume (30 Days)
- STHO 27.4K
- TVGN 111.4K
- Earning Date
- STHO 08-06-2024
- TVGN 08-14-2024
- Dividend Yield
- STHO N/A
- TVGN N/A
- EPS Growth
- STHO N/A
- TVGN N/A
- EPS
- STHO N/A
- TVGN N/A
- Revenue
- STHO $136,773,000.00
- TVGN N/A
- Revenue This Year
- STHO N/A
- TVGN N/A
- Revenue Next Year
- STHO N/A
- TVGN N/A
- P/E Ratio
- STHO N/A
- TVGN N/A
- Revenue Growth
- STHO 38.53
- TVGN N/A
- 52 Week Low
- STHO $10.76
- TVGN $0.41
- 52 Week High
- STHO $15.31
- TVGN $21.09
- Technical
- Relative Strength Index (RSI)
- STHO 49.18
- TVGN 30.23
- Support Level
- STHO $12.56
- TVGN $0.48
- Resistance Level
- STHO $13.36
- TVGN $0.50
- Average True Range (ATR)
- STHO 0.30
- TVGN 0.07
- MACD
- STHO -0.03
- TVGN -0.01
- Stochastic Oscillator
- STHO 35.43
- TVGN 3.60
About STHO Star Holdings Shares of Beneficial Interest
Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. It focuses on realizing value for shareholders from the legacy portfolio by maximizing cash flows through active asset management and asset sales.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.